Nunavut – The Governments of Canada and Nunavut signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $7.3 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases. In March 2023, the Government of Canada announced …
Nova Scotia – The Governments of Canada and Nova Scotia signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $39 million over three years to improve access to new drugs for rare diseases for Nova Scotia residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases. In March 2023, the Government …
Ottawa – The Governments of Canada and Alberta signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest a total amount of over $162 million over three years to improve access to new drugs for rare diseases for its residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases. In March 2023, …
Ottawa – Governments of Canada and Newfoundland and Labrador signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest a total amount of over $22 million over three years to improve access to new drugs for rare diseases for its residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases. In March 2023, the …
